ENFN - Enfusion Inc. (ENFN) Q1 2024 Earnings Call Transcript
2024-05-11 12:13:13 ET
Enfusion, Inc. (ENFN)
Q1 2024 Earnings Conference Call
May 9, 2024, 8:30 AM ET
Company Participants
Bill Wright - Head, Investor Relations
Oleg Movchan - Chief Executive Officer
Brad Herring - Chief Financial Officer
Neal Pawar - Chief Operating Officer
Conference Call Participants
Michael Infante - Morgan Stanley
Faith Brunner - William Blair
Jeffrey Lane - Stifel
Kevin McVeigh - UBS
Alexei Gogolev - JPMorgan
Gabriela Borges - Goldman Sachs
Koji Ikeda - Bank of America
Presentation
Operator
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion’s First Quarter 2024 Earnings Conference Call. At this time, all lines have been placed on mute to prevent any background noise. Following the speakers’ remarks, there -- we will open up the lines for your questions. As a reminder, this conference call is being recorded.
I’d now like to turn the call over to Bill Wright, Head of Investor Relations to begin.
Bill Wright
Good morning, and thank you, Operator. We welcome you to Enfusion’s first quarter 2024 earnings conference call. Hosting today’s call are Oleg Movchan, Enfusion’s Chief Executive Officer; Brad Herring, Enfusion’s Chief Financial Officer; and Neal Pawar, Enfusion’s Chief Operating Officer. Please note, our quarterly shareholder letter, which includes our quarterly financial results, has been posted to our Investor Relations website.
I would like to remind you that today’s call may contain forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC, which are available in the Investor Relations section of our website.
Actual results may differ materially from any forward-looking statements we make today. These forward-looking statements speak only as of today and the company does not assume any obligation or intent to update them following today’s call, except as required by law.
In addition, today’s call may include non-GAAP measures. These measures should be considered as a supplement to and not a substitute for GAAP financial measures. Reconciliation to the nearest GAAP measures can be found in today’s quarterly shareholder letter, which is available on the company’s website.
With that, I’d like to turn the call over to Oleg to begin.
Oleg Movchan
Good morning. And thank you for joining us today to discuss our results for the first quarter of 2024. I’d like to start by sharing my excitement about the direction of our business and our team’s ability to execute on our strategy.
As you will hear from me, as well as our COO, Neal Pawar, and CFO, Brad Herring shortly, the value proposition we have shared with all of you in the investment community and bring to market every day is resonating and I am incredibly proud of everyone at Enfusion for their hard work and dedication....
Enfusion, Inc. (ENFN) Q1 2024 Earnings Call Transcript